Guardant Health in Palo Alto, CA is seeking a PhD- or MSc-qualified scientist to lead LC–MS method development for small molecules, lipids, and peptides. The role requires hands-on PRM (HRMS) expertise and strong quantitative LC–MS workflow knowledge
Programmable Medicine is a pre-revenue, clinical-stage biotechnology company focused on discovering and developing innovative therapies for patients with serious diseases. The company operates across multiple legal entities and partners with external CROs, CMOs, and research institutions
Retro develops therapies for diseases driven by the biology of aging. We focus on cellular reprogramming and autophagy to broadly improve tissue function by targeting mechanisms of aging with the ultimate aim of adding 10 years
Genentech’s Analytical Development & Quality Control (ADQC) team is expanding. As a core division within Genentech’s Pharma Technical Cell & Gene Therapy organization, we ensure the safety, efficacy and quality of cell therapies. ADQC develops, validates and
The application window is expected to close on: 08/31/2026 Job posting may be removed earlier if the position is filled or if a sufficient number of applications are received. This role is hybrid in San Jose,
At Gilead, we’re creating a healthier world for all people. For more than 35 years, we’ve tackled diseases such as HIV, viral hepatitis, COVID-19 and cancer – working relentlessly to develop therapies that help improve lives
Neurodegenerative diseases are one of the largest medical challenges of our time. Denali Therapeutics is a biotechnology company dedicated to developing breakthrough therapies for neurodegenerative diseases through our deep commitment to degeneration biology and principles of
Scientist – Analytical Development & Quality Control South San Francisco, CA | May 2026 Addition Therapeutics leads in biotechnology innovation, advancing transformative therapies through our proprietary PRINT platform (Precise RNA-mediated Insertion of Transgenes). PRINT redefines genetic medicine
Associate/Director, Analytical Development 2 days ago Be among the first 25 applicants This range is provided by GondolaBio. Your actual pay will be based on your skills and experience — talk with your recruiter to learn more.Base
Work Location This is an on-site position based at our corporate Headquarters (South San Francisco)Position Summary TCG Labs-Soleil is looking for an experienced analytical lead to join our CMC team. We are seeking a highly skilled and
Retro develops therapies for diseases driven by the biology of aging. We focus on cellular reprogramming and autophagy to broadly improve tissue function by targeting mechanisms of aging with the ultimate aim of adding 10 years
Alumis Inc. is a precision medicines company with the mission to transform the lives of patients with autoimmune diseases. Even with treatment innovations of the last two decades, many patients with immunologic conditions continue to suffer
Eikon Therapeutics is a new biopharmaceutical company employing revolutionary technology at the intersection of chemistry, engineering, computation, and biology to discover novel treatments for life-threatening diseases. Eikon’s discovery platform is built on groundbreaking innovations from its
Analytical CharacterizationsOctober 2025 Department: Technology Position Summary: Soleil is seeking an expert and engaged Associate Director / Director, Analytical Lead to head our analytical and biophysical characterization efforts within the Protein Sciences group of the Biologics Technology team. In
Company Overview Nurix Therapeutics is a clinical stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted protein degradation medicines, the next frontier in innovative drug design aimed at improving treatment options for patients
Alumis Inc. in South San Francisco is looking for a Sr. Scientist I in Analytical Development. In this role, you will support analytical development and quality control activities from preclinical to late-stage clinical development. The ideal candidate will
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS‑addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
ORIC Pharmaceuticals is a clinical stage biopharmaceutical company dedicated to improving patients’ lives by Overcoming Resistance In Cancer. ORIC’s clinical stage product candidates include (1) rinzimetostat (ORIC-944), an allosteric inhibitor of the polycomb repressive complex 2
Senior Scientist I Analytical Development Alumis Inc. is a precision medicines company with the mission to transform the lives of patients with autoimmune diseases. Even with treatment innovations of the last two decades, many patients with immunologic
Overview Genentech’s Analytical Development & Quality Control (ADQC) team, part of the Pharma Technical Cell & Gene Therapy organization, is expanding. The team ensures the safety, efficacy and quality of cell therapies by developing, validating and executing